Secretory Immunoglobulin a (SigA) Testing in Saliva from End-Stage Patients with Chronic Kidney Disease Undergoing Dialysis Treatment and in Control Healthy Subjects

Nenova-Nogalcheva A.; Konstantinova D.; Pechalova P.

doi:10.2478/amb-2020-0017

Acta Medica Bulgarica (Jul 2020)

Secretory Immunoglobulin a (SigA) Testing in Saliva from End-Stage Patients with Chronic Kidney Disease Undergoing Dialysis Treatment and in Control Healthy Subjects

Nenova-Nogalcheva A.,
Konstantinova D.,
Pechalova P.

Affiliations

Nenova-Nogalcheva A.: Department of Oral and Maxillofacial Surgery, Medical University – Varna, Bulgaria
Konstantinova D.: Department of Prosthetic Dentistry, Medical University – Varna, Bulgaria
Pechalova P.: Department of Oral Surgery, Medical University – Plovdiv, Bulgaria

DOI: https://doi.org/10.2478/amb-2020-0017
Journal volume & issue: Vol. 47, no. 2
pp. 18 – 21

Abstract

Read online

The purpose of the present study was to measure SIgA levels in saliva in control healthy patients and in patients with end-stage chronic kidney disease (CKD) undergoing dialysis treatment.

Published in Acta Medica Bulgarica

ISSN: 0324-1750 (Print); 2719-5384 (Online)
Publisher: Sciendo
Country of publisher: Poland
LCC subjects: Medicine
Website: https://sciendo.com/journal/AMB

About the journal

Abstract

Keywords